PGIRX
Price
$27.09
Change
+$0.01 (+0.04%)
Updated
Oct 15 closing price
Net Assets
319.24M
RNPFX
Price
$73.89
Change
+$0.40 (+0.54%)
Updated
Oct 15 closing price
Net Assets
162.01B
Interact to see
Advertisement

PGIRX vs RNPFX

Header iconPGIRX vs RNPFX Comparison
Open Charts PGIRX vs RNPFXBanner chart's image
Polen Global Growth Investor
Price$27.09
Change+$0.01 (+0.04%)
VolumeN/A
Net Assets319.24M
American Funds New Perspective R5
Price$73.89
Change+$0.40 (+0.54%)
VolumeN/A
Net Assets162.01B
PGIRX vs RNPFX Comparison Chart in %
View a ticker or compare two or three
VS
PGIRX vs. RNPFX commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGIRX is a Hold and RNPFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPFX has more cash in the bank: 162B vs. PGIRX (319M). RNPFX pays higher dividends than PGIRX: RNPFX (0.70) vs PGIRX (0.00). PGIRX was incepted earlier than RNPFX: PGIRX (10 years) vs RNPFX (23 years). PGIRX (1.26) is less costly to investors than RNPFX (0.46). PGIRX is a more actively managed with annual turnover of: 32.00 vs. RNPFX (24.00). RNPFX has a lower initial minimum investment than PGIRX: RNPFX (250) vs PGIRX (3000). RNPFX annual gain was more profitable for investors over the last year : 13.49 vs. PGIRX (2.89). RNPFX return over 5 years is better than : 36.21 vs. PGIRX (20.20).
PGIRXRNPFXPGIRX / RNPFX
Total Expense Ratio1.260.46274%
Annual Report Gross Expense Ratio1.260.46274%
Fund Existence10 years23 years-
Gain YTD4.75819.10125%
Front LoadN/AN/A-
Min. Initial Investment30002501,200%
Min. Initial Investment IRAN/AN/A-
Net Assets319M162B0%
Annual Yield % from dividends0.000.70-
Returns for 1 year2.8913.4921%
Returns for 3 years56.6268.3683%
Returns for 5 years20.2036.2156%
Returns for 10 years156.5199.90157%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATRC37.031.64
+4.63%
AtriCure
INKT14.800.65
+4.59%
MiNK Therapeutics Inc
IPCXU10.550.12
+1.15%
Inflection Point Acquisition Corp
LCTX1.810.02
+1.12%
Lineage Cell Therapeutics
CUBE41.110.21
+0.51%
CubeSmart